Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Abdominal Aortic Aneurysm Prevention
Research from Ghent University broadens understanding of abdominal aortic aneurysm prevention
April 6th, 2008
Research findings, 'Long-term surveillance is paramount after implantation of the Vanguard stent-graft for abdominal aortic aneurysms,' are discussed in a new report. "The aim of this study was to describe the results and long-term follow-up of the Vanguard endovascular graft for infrarenal abdominal aortic aneurysm (AAA) repair. Between February 1997 and October 1999, 76 patients were treated with a median aneurysm diameter of 52 mm (39-90 mm)," researchers in Ghent, Belgium report. "All were followed up according to the Eurostar criteria. The primary technical success rate was 100%. Perioperative mortality was 1.3%. During follow-up (median 75 months, 6-112 months) 9...
Source: Pharma Investments, Ventures & Law Weekly (2008-04-06)
|
